TrialCardiovascular diabetology2017

Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: a pilot study.

Ryotaro Bouchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.